Renaissance Capital logo

Xynomic Pharmaceuticals (Bison Capital Acquisition) Priced, Nasdaq: XYNO.XX

Chinese blank check company formed by a former partner at NEA (completed 5/15/2019).

Industry: SPAC

First Day Return: +0.7%

Industry: SPAC

Bison Capital Acquisition Corp. is a newly organized blank check company incorporated in the British Virgin Islands as a business company and formed for the purpose of acquiring, engaging in a share exchange, share reconstruction and amalgamation with, purchasing all or substantially all of the assets of, entering into contractual arrangements with, or engaging in any other similar business combination with one or more businesses. Although we are not limited to a particular industry or geographic region for purposes of consummating an initial business combination, we intend to focus on businesses that have their primary operations located in Asia and North America.
more less
IPO Data
IPO File Date 06/01/2017
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 5.3
Deal Size ($mm) $53
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 06/19/2017
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $53
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters Beijing, China
Founded 2016
Employees at IPO 3

Xynomic Pharmaceuticals (Bison Capital Acquisition) (XYNO.XX) Performance